$ULGX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in UROLOGIX INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in UROLOGIX INC. Get notifications about new insider transactions in UROLOGIX INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 02 2015 | ULGX | UROLOGIX INC | Madson Scott M. | Chief Financial Off ... | Option Exercise | A | 0.08 | 150,000 | 12,000 | 150,000 | |
Nov 24 2014 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Sell | S | 0.09 | 10,000 | 854 | 164,031 | 174 K to 164 K (-5.75 %) |
Nov 24 2014 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Sell | S | 0.09 | 10,000 | 854 | 174,031 | 184 K to 174 K (-5.43 %) |
Nov 21 2014 | ULGX | UROLOGIX INC | Spangler Patrick D | Director | Grant | A | 0.00 | 45,455 | 0 | 155,257 | 109.8 K to 155.3 K (+41.40 %) |
Nov 21 2014 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Grant | A | 0.00 | 45,455 | 0 | 184,031 | 138.6 K to 184 K (+32.80 %) |
Nov 21 2014 | ULGX | UROLOGIX INC | DANN MITCHELL | Director | Grant | A | 0.00 | 45,455 | 0 | 530,346 | 484.9 K to 530.3 K (+9.37 %) |
Nov 21 2014 | ULGX | UROLOGIX INC | Barys Christopher R | Director | Grant | A | 0.00 | 45,455 | 0 | 155,257 | 109.8 K to 155.3 K (+41.40 %) |
Aug 15 2014 | ULGX | UROLOGIX INC | Fluet Gregory | CEO | Grant | A | 0.00 | 60,000 | 0 | 110,000 | 50 K to 110 K (+120.00 %) |
Aug 15 2014 | ULGX | UROLOGIX INC | Ackermann Lisa A | EVP, Sales and Mark ... | Grant | A | 0.00 | 40,000 | 0 | 120,632 | 80.6 K to 120.6 K (+49.61 %) |
Jan 22 2014 | ULGX | UROLOGIX INC | Spangler Patrick D | Director | Grant | A | 0.00 | 50,000 | 0 | 109,802 | 59.8 K to 109.8 K (+83.61 %) |
Jan 22 2014 | ULGX | UROLOGIX INC | Barys Christopher R | Director | Grant | A | 0.00 | 50,000 | 0 | 109,802 | 59.8 K to 109.8 K (+83.61 %) |
Jan 22 2014 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Grant | A | 0.00 | 50,000 | 0 | 138,576 | 88.6 K to 138.6 K (+56.45 %) |
Jan 22 2014 | ULGX | UROLOGIX INC | DANN MITCHELL | Director | Grant | A | 0.00 | 50,000 | 0 | 484,891 | 434.9 K to 484.9 K (+11.50 %) |
Aug 28 2013 | ULGX | UROLOGIX INC | Fluet Gregory | CEO | Buy | P | 0.31 | 17,500 | 5,425 | 17,500 | 0 to 17.5 K |
Aug 16 2013 | ULGX | UROLOGIX INC | Fluet Gregory | CEO | Option Exercise | A | 0.38 | 50,000 | 19,000 | 50,000 | |
Aug 16 2013 | ULGX | UROLOGIX INC | Fluet Gregory | CEO | Grant | A | 0.00 | 39,474 | 0 | 161,874 | 122.4 K to 161.9 K (+32.25 %) |
Aug 16 2013 | ULGX | UROLOGIX INC | Fluet Gregory | CEO | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Aug 16 2013 | ULGX | UROLOGIX INC | Smrdel Brian J | Chief Financial Off ... | Option Exercise | A | 0.38 | 17,500 | 6,650 | 17,500 | |
Aug 16 2013 | ULGX | UROLOGIX INC | Smrdel Brian J | Chief Financial Off ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Aug 16 2013 | ULGX | UROLOGIX INC | Ackermann Lisa A | EVP, Sales & Market ... | Option Exercise | A | 0.38 | 35,000 | 13,300 | 35,000 | |
Aug 16 2013 | ULGX | UROLOGIX INC | Ackermann Lisa A | EVP, Sales & Market ... | Grant | A | 0.00 | 35,000 | 0 | 80,632 | 45.6 K to 80.6 K (+76.70 %) |
Jul 09 2013 | ULGX | UROLOGIX INC | Fluet Gregory | CEO | Buy | P | 0.20 | 30,000 | 6,000 | 97,400 | 67.4 K to 97.4 K (+44.51 %) |
Jul 09 2013 | ULGX | UROLOGIX INC | Fluet Gregory | CEO | Buy | P | 0.17 | 20,000 | 3,400 | 67,400 | 47.4 K to 67.4 K (+42.19 %) |
Jul 09 2013 | ULGX | UROLOGIX INC | Fluet Gregory | CEO | Buy | P | 0.21 | 11,200 | 2,296 | 47,400 | 36.2 K to 47.4 K (+30.94 %) |
Jul 09 2013 | ULGX | UROLOGIX INC | Fluet Gregory | CEO | Buy | P | 0.21 | 5,200 | 1,085 | 36,200 | 31 K to 36.2 K (+16.77 %) |
Jul 15 2013 | ULGX | UROLOGIX INC | DANN MITCHELL | Director | Buy | P | 0.30 | 20,000 | 6,000 | 614,891 | 594.9 K to 614.9 K (+3.36 %) |
Jul 11 2013 | ULGX | UROLOGIX INC | Fluet Gregory | CEO | Buy | P | 0.24 | 25,000 | 6,000 | 122,400 | 97.4 K to 122.4 K (+25.67 %) |
Jul 10 2013 | ULGX | UROLOGIX INC | Ackermann Lisa A | EVP, Sales & Market ... | Buy | P | 0.24 | 18,500 | 4,440 | 18,500 | 0 to 18.5 K |
Feb 04 2013 | ULGX | UROLOGIX INC | Fluet Gregory | Interim CEO | Option Exercise | M | 0.78 | 20,000 | 15,600 | 0 | |
Feb 04 2013 | ULGX | UROLOGIX INC | Fluet Gregory | Interim CEO | Buy | M | 0.78 | 20,000 | 15,600 | 31,000 | 11 K to 31 K (+181.82 %) |
Dec 05 2012 | ULGX | UROLOGIX INC | Fluet Gregory | Interim CEO | Buy | P | 0.65 | 100 | 65 | 11,000 | 10.9 K to 11 K (+0.92 %) |
Dec 05 2012 | ULGX | UROLOGIX INC | Fluet Gregory | Interim CEO | Buy | P | 0.66 | 2,778 | 1,833 | 10,900 | 8.1 K to 10.9 K (+34.20 %) |
Dec 05 2012 | ULGX | UROLOGIX INC | Fluet Gregory | Interim CEO | Buy | P | 0.64 | 7,122 | 4,587 | 8,122 | 1,000 to 8.1 K (+712.20 %) |
Nov 19 2012 | ULGX | UROLOGIX INC | Spangler Patrick D | Director | Option Exercise | A | 0.66 | 10,000 | 6,600 | 10,000 | |
Nov 19 2012 | ULGX | UROLOGIX INC | Spangler Patrick D | Director | Grant | A | 0.00 | 26,516 | 0 | 59,802 | 33.3 K to 59.8 K (+79.66 %) |
Nov 19 2012 | ULGX | UROLOGIX INC | DANN MITCHELL | Director | Option Exercise | A | 0.66 | 10,000 | 6,600 | 10,000 | |
Nov 19 2012 | ULGX | UROLOGIX INC | DANN MITCHELL | Director | Grant | A | 0.00 | 26,516 | 0 | 594,891 | 568.4 K to 594.9 K (+4.67 %) |
Nov 19 2012 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Option Exercise | A | 0.66 | 10,000 | 6,600 | 10,000 | |
Nov 19 2012 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Grant | A | 0.00 | 26,516 | 0 | 88,576 | 62.1 K to 88.6 K (+42.73 %) |
Nov 19 2012 | ULGX | UROLOGIX INC | Barys Christopher R | Director | Option Exercise | A | 0.66 | 10,000 | 6,600 | 10,000 | |
Nov 19 2012 | ULGX | UROLOGIX INC | Barys Christopher R | Director | Grant | A | 0.00 | 26,516 | 0 | 59,802 | 33.3 K to 59.8 K (+79.66 %) |
Aug 14 2012 | ULGX | UROLOGIX INC | Fluet Gregory | EVP & Chief Operati ... | Option Exercise | A | 0.87 | 30,000 | 26,100 | 30,000 | |
Aug 14 2012 | ULGX | UROLOGIX INC | Ackermann Lisa A | EVP, Sales & Market ... | Option Exercise | A | 0.87 | 25,000 | 21,750 | 25,000 | |
Jul 02 2012 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Buy | P | 0.75 | 20,000 | 15,000 | 62,060 | 42.1 K to 62.1 K (+47.55 %) |
Jul 02 2012 | ULGX | UROLOGIX INC | DANN MITCHELL | Director | Buy | P | 0.75 | 100,000 | 75,000 | 110,358 | 10.4 K to 110.4 K (+965.44 %) |
Jul 02 2012 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Buy | P | 0.75 | 200,000 | 150,000 | 457,280 | 257.3 K to 457.3 K (+77.74 %) |
May 17 2012 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Option Exercise | M | 0.91 | 10,833 | 9,858 | 37,917 | |
May 17 2012 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Buy | M | 0.91 | 10,833 | 9,858 | 257,280 | 246.4 K to 257.3 K (+4.40 %) |
Dec 07 2011 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Buy | P | 1.02 | 5,000 | 5,100 | 20,000 | 15 K to 20 K (+33.33 %) |
Dec 05 2011 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Buy | P | 1.00 | 100 | 100 | 15,000 | 14.9 K to 15 K (+0.67 %) |
Dec 05 2011 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Buy | P | 1.02 | 4,900 | 4,998 | 14,900 | 10 K to 14.9 K (+49.00 %) |
Dec 05 2011 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Buy | P | 1.02 | 10,000 | 10,200 | 10,000 | 0 to 10 K |
Nov 09 2011 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Option Exercise | A | 0.97 | 10,000 | 9,700 | 10,000 | |
Nov 09 2011 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Grant | A | 0.00 | 18,042 | 0 | 42,060 | 24 K to 42.1 K (+75.12 %) |
Nov 09 2011 | ULGX | UROLOGIX INC | Spangler Patrick D | Director | Option Exercise | A | 0.97 | 10,000 | 9,700 | 10,000 | |
Nov 09 2011 | ULGX | UROLOGIX INC | Spangler Patrick D | Director | Grant | A | 0.00 | 18,042 | 0 | 33,286 | 15.2 K to 33.3 K (+118.35 %) |
Nov 09 2011 | ULGX | UROLOGIX INC | Barys Christopher R | Director | Option Exercise | A | 0.97 | 10,000 | 9,700 | 10,000 | |
Nov 09 2011 | ULGX | UROLOGIX INC | Barys Christopher R | Director | Grant | A | 0.00 | 18,042 | 0 | 33,286 | 15.2 K to 33.3 K (+118.35 %) |
Nov 09 2011 | ULGX | UROLOGIX INC | DANN MITCHELL | Director | Option Exercise | A | 0.97 | 10,000 | 9,700 | 10,000 | |
Nov 09 2011 | ULGX | UROLOGIX INC | DANN MITCHELL | Director | Grant | A | 0.00 | 18,042 | 0 | 468,375 | 450.3 K to 468.4 K (+4.01 %) |
Sep 02 2011 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Option Exercise | M | 0.91 | 16,250 | 14,788 | 48,750 | |
Sep 02 2011 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Option Exercise | M | 1.30 | 49,997 | 64,996 | 50,003 | |
Sep 02 2011 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Buy | M | 0.91 | 16,250 | 14,788 | 246,447 | 230.2 K to 246.4 K (+7.06 %) |
Sep 02 2011 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Buy | M | 1.30 | 49,997 | 64,996 | 230,197 | 180.2 K to 230.2 K (+27.75 %) |
Aug 25 2011 | ULGX | UROLOGIX INC | Cardinal Ralph Peter | VP Research & Devel ... | Option Exercise | A | 0.88 | 20,000 | 17,600 | 20,000 | |
Aug 25 2011 | ULGX | UROLOGIX INC | Smrdel Brian J | Chief Financial Off ... | Option Exercise | A | 0.88 | 20,000 | 17,600 | 20,000 | |
Aug 25 2011 | ULGX | UROLOGIX INC | Fluet Gregory | EVP & Chief Operati ... | Option Exercise | A | 0.88 | 50,000 | 44,000 | 50,000 | |
Jun 17 2011 | ULGX | UROLOGIX INC | Ackermann Lisa A | VP, Sales & Marketi ... | Option Exercise | A | 1.03 | 100,000 | 103,000 | 100,000 | |
Jun 17 2011 | ULGX | UROLOGIX INC | Ackermann Lisa A | VP, Sales & Marketi ... | Grant | A | 0.00 | 45,632 | 0 | 45,632 | 0 to 45.6 K |
Feb 01 2011 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Buy | P | 0.59 | 5,200 | 3,068 | 180,200 | 175 K to 180.2 K (+2.97 %) |
Nov 19 2010 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Buy | P | 0.80 | 3,527 | 2,822 | 175,000 | 171.5 K to 175 K (+2.06 %) |
Nov 19 2010 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Buy | P | 0.79 | 200 | 158 | 171,473 | 171.3 K to 171.5 K (+0.12 %) |
Nov 19 2010 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Buy | P | 0.78 | 2,000 | 1,560 | 171,273 | 169.3 K to 171.3 K (+1.18 %) |
Nov 19 2010 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Buy | P | 0.76 | 3,951 | 3,003 | 169,273 | 165.3 K to 169.3 K (+2.39 %) |
Nov 18 2010 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Buy | P | 0.76 | 322 | 245 | 165,322 | 165 K to 165.3 K (+0.20 %) |
Nov 10 2010 | ULGX | UROLOGIX INC | DANN MITCHELL | Director | Option Exercise | A | 0.82 | 10,000 | 8,200 | 10,000 | |
Nov 10 2010 | ULGX | UROLOGIX INC | DANN MITCHELL | Director | Grant | A | 0.00 | 15,244 | 0 | 450,333 | 435.1 K to 450.3 K (+3.50 %) |
Nov 10 2010 | ULGX | UROLOGIX INC | Barys Christopher R | Director | Option Exercise | A | 0.82 | 10,000 | 8,200 | 10,000 | |
Nov 10 2010 | ULGX | UROLOGIX INC | Barys Christopher R | Director | Grant | A | 0.00 | 15,244 | 0 | 15,244 | 0 to 15.2 K |
Nov 10 2010 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Option Exercise | A | 0.82 | 10,000 | 8,200 | 10,000 | |
Nov 10 2010 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Grant | A | 0.00 | 15,244 | 0 | 24,018 | 8.8 K to 24 K (+173.74 %) |
Nov 10 2010 | ULGX | UROLOGIX INC | Spangler Patrick D | Director | Option Exercise | A | 0.82 | 10,000 | 8,200 | 10,000 | |
Nov 10 2010 | ULGX | UROLOGIX INC | Spangler Patrick D | Director | Grant | A | 0.00 | 15,244 | 0 | 15,244 | 0 to 15.2 K |
Aug 31 2010 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Option Exercise | A | 0.91 | 65,000 | 59,150 | 65,000 | |
Aug 31 2010 | ULGX | UROLOGIX INC | Fluet Gregory | EVP & Chief Operati ... | Option Exercise | A | 0.91 | 55,000 | 50,050 | 55,000 | |
Aug 31 2010 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Buy | P | 0.79 | 5,000 | 3,950 | 165,000 | 160 K to 165 K (+3.13 %) |
May 11 2010 | ULGX | UROLOGIX INC | Smrdel Brian J | Chief Financial Off ... | Option Exercise | A | 1.40 | 65,000 | 91,000 | 65,000 | |
Dec 21 2009 | ULGX | UROLOGIX INC | DANN MITCHELL | Director | Gift | G | 0.00 | 21,666 | 0 | 61,684 | 40 K to 61.7 K (+54.14 %) |
Dec 21 2009 | ULGX | UROLOGIX INC | DANN MITCHELL | Director | Gift | G | 0.00 | 21,666 | 0 | 435,089 | 456.8 K to 435.1 K (-4.74 %) |
Dec 08 2009 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Buy | P | 1.14 | 11,900 | 13,566 | 160,000 | 148.1 K to 160 K (+8.04 %) |
Dec 08 2009 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Buy | P | 1.10 | 5,000 | 5,500 | 148,100 | 143.1 K to 148.1 K (+3.49 %) |
Dec 07 2009 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Buy | P | 1.12 | 3,100 | 3,472 | 143,100 | 140 K to 143.1 K (+2.21 %) |
Nov 18 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 1.00 | 5,000 | 5,000 | 10,000 | 5 K to 10 K (+100.00 %) |
Nov 18 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 1.00 | 5,000 | 5,000 | 9,000 | 4 K to 9 K (+125.00 %) |
Nov 18 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.95 | 5,000 | 4,750 | 5,000 | 0 to 5 K |
Nov 18 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.95 | 5,000 | 4,750 | 59,154 | 54.2 K to 59.2 K (+9.23 %) |
Nov 12 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Option Exercise | A | 1.06 | 10,000 | 10,600 | 10,000 | |
Nov 12 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Grant | A | 0.00 | 8,774 | 0 | 54,154 | 45.4 K to 54.2 K (+19.33 %) |
Nov 12 2009 | ULGX | UROLOGIX INC | Jackson Guy C. | Director | Option Exercise | A | 1.06 | 10,000 | 10,600 | 10,000 | |
Nov 12 2009 | ULGX | UROLOGIX INC | Jackson Guy C. | Director | Grant | A | 0.00 | 8,774 | 0 | 16,774 | 8 K to 16.8 K (+109.68 %) |
Nov 12 2009 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Option Exercise | A | 1.06 | 10,000 | 10,600 | 10,000 | |
Nov 12 2009 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Grant | A | 0.00 | 8,774 | 0 | 8,774 | 0 to 8.8 K |
Nov 12 2009 | ULGX | UROLOGIX INC | DANN MITCHELL | Director | Option Exercise | A | 1.06 | 10,000 | 10,600 | 10,000 | |
Nov 12 2009 | ULGX | UROLOGIX INC | DANN MITCHELL | Director | Grant | A | 0.00 | 8,774 | 0 | 456,755 | 448 K to 456.8 K (+1.96 %) |
Aug 31 2009 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Buy | P | 1.20 | 1,635 | 1,962 | 138,130 | 136.5 K to 138.1 K (+1.20 %) |
Sep 03 2009 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Buy | P | 1.20 | 1,870 | 2,244 | 140,000 | 138.1 K to 140 K (+1.35 %) |
Aug 10 2009 | ULGX | UROLOGIX INC | Weber Rebecca J | Dir. of Finance & C ... | Option Exercise | A | 1.30 | 15,000 | 19,500 | 15,000 | |
Aug 10 2009 | ULGX | UROLOGIX INC | Fluet Gregory | EVP & Chief Operati ... | Option Exercise | A | 1.30 | 50,000 | 65,000 | 50,000 | |
Aug 10 2009 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Option Exercise | A | 1.30 | 100,000 | 130,000 | 100,000 | |
May 29 2009 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Buy | P | 1.00 | 1,495 | 1,495 | 136,495 | 135 K to 136.5 K (+1.11 %) |
May 18 2009 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Buy | P | 1.00 | 5,000 | 5,000 | 135,000 | 130 K to 135 K (+3.85 %) |
May 13 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.85 | 1,500 | 1,275 | 45,380 | 43.9 K to 45.4 K (+3.42 %) |
May 05 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.85 | 100 | 85 | 43,880 | 43.8 K to 43.9 K (+0.23 %) |
May 04 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.82 | 563 | 462 | 43,780 | 43.2 K to 43.8 K (+1.30 %) |
May 04 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.82 | 200 | 164 | 43,217 | 43 K to 43.2 K (+0.46 %) |
May 04 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.78 | 737 | 575 | 43,017 | 42.3 K to 43 K (+1.74 %) |
May 01 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.85 | 1,500 | 1,275 | 42,280 | 40.8 K to 42.3 K (+3.68 %) |
Dec 19 2008 | ULGX | UROLOGIX INC | DANN MITCHELL | Director | Option Exercise | M | 0.79 | 10,000 | 7,900 | 0 | |
Dec 19 2008 | ULGX | UROLOGIX INC | DANN MITCHELL | Director | Buy | M | 0.79 | 10,000 | 7,900 | 447,981 | 438 K to 448 K (+2.28 %) |
Nov 13 2008 | ULGX | UROLOGIX INC | STARKS DANIEL J | Director | Option Exercise | A | 0.79 | 10,000 | 7,900 | 10,000 | |
Nov 13 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Option Exercise | A | 0.79 | 10,000 | 7,900 | 10,000 | |
Nov 13 2008 | ULGX | UROLOGIX INC | Jackson Guy C. | Director | Option Exercise | A | 0.79 | 10,000 | 7,900 | 10,000 | |
Nov 13 2008 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Option Exercise | A | 0.79 | 10,000 | 7,900 | 10,000 | |
Nov 13 2008 | ULGX | UROLOGIX INC | Cirino Jerry C | Director | Option Exercise | A | 0.79 | 10,000 | 7,900 | 10,000 | |
Nov 13 2008 | ULGX | UROLOGIX INC | DANN MITCHELL | Director | Option Exercise | A | 0.79 | 10,000 | 7,900 | 10,000 | |
Aug 18 2008 | ULGX | UROLOGIX INC | DANN MITCHELL | Director | Option Exercise | A | 1.84 | 30,000 | 55,200 | 30,000 | |
Aug 18 2008 | ULGX | UROLOGIX INC | Weber Rebecca J | Controller & Dir. o ... | Option Exercise | A | 1.84 | 17,000 | 31,280 | 17,000 | |
Jul 16 2008 | ULGX | UROLOGIX INC | Fluet Gregory | EVP and COO | Option Exercise | A | 1.85 | 75,000 | 138,750 | 75,000 | |
Jun 26 2008 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Option Exercise | A | 1.79 | 355,000 | 635,450 | 355,000 | |
Jun 26 2008 | ULGX | UROLOGIX INC | Warren Stryker Jr | Chief Executive Off ... | Grant | A | 0.00 | 80,000 | 0 | 130,000 | 50 K to 130 K (+160.00 %) |
Jun 03 2008 | ULGX | UROLOGIX INC | DANN MITCHELL | Interim Chief Execu ... | Option Exercise | M | 0.78 | 40,000 | 31,200 | 0 | |
Jun 03 2008 | ULGX | UROLOGIX INC | DANN MITCHELL | Interim Chief Execu ... | Option Exercise | M | 0.78 | 10,000 | 7,800 | 0 | |
Jun 03 2008 | ULGX | UROLOGIX INC | DANN MITCHELL | Interim Chief Execu ... | Buy | M | 0.78 | 40,000 | 31,200 | 437,981 | 398 K to 438 K (+10.05 %) |
Jun 03 2008 | ULGX | UROLOGIX INC | DANN MITCHELL | Interim Chief Execu ... | Buy | M | 0.78 | 10,000 | 7,800 | 397,981 | 388 K to 398 K (+2.58 %) |
May 28 2008 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Buy | P | 1.18 | 10,000 | 11,800 | 51,247 | 41.2 K to 51.2 K (+24.24 %) |
May 28 2008 | ULGX | UROLOGIX INC | EMERY SIDNEY W JR | Director | Buy | P | 1.16 | 10,000 | 11,600 | 41,247 | 31.2 K to 41.2 K (+32.00 %) |
May 23 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 1.11 | 500 | 555 | 40,780 | 40.3 K to 40.8 K (+1.24 %) |
May 14 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.96 | 4,000 | 3,840 | 39,800 | 35.8 K to 39.8 K (+11.17 %) |
May 14 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.95 | 1,000 | 950 | 35,800 | 34.8 K to 35.8 K (+2.87 %) |
May 14 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.94 | 1,000 | 940 | 34,800 | 33.8 K to 34.8 K (+2.96 %) |
May 14 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.93 | 1,000 | 930 | 33,800 | 32.8 K to 33.8 K (+3.05 %) |
May 16 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.98 | 480 | 470 | 40,280 | 39.8 K to 40.3 K (+1.21 %) |
May 12 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.93 | 800 | 744 | 32,800 | 32 K to 32.8 K (+2.50 %) |
May 12 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.92 | 4,000 | 3,680 | 32,000 | 28 K to 32 K (+14.29 %) |
May 12 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.91 | 1,000 | 910 | 28,000 | 27 K to 28 K (+3.70 %) |
May 12 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.91 | 1,000 | 910 | 27,000 | 26 K to 27 K (+3.85 %) |
May 08 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.93 | 1,000 | 930 | 26,000 | 25 K to 26 K (+4.00 %) |
Apr 17 2008 | ULGX | UROLOGIX INC | Weber Rebecca J | Controller & Dir. o ... | Option Exercise | A | 0.87 | 28,000 | 24,360 | 28,000 | |
Mar 07 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.98 | 2,000 | 1,960 | 25,000 | 23 K to 25 K (+8.70 %) |
Mar 07 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.97 | 5,000 | 4,850 | 23,000 | 18 K to 23 K (+27.78 %) |